11.01.2007
opracowano na podstawie: Treatment with 400 µg of inhaled budesonide vs 200 µg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial
Gokul C. Jat, Joseph L. Mathew, Meenu Singh
Annals of Allergy, Asthma & Immunology, 2006; 97: 397–401